1. Home
  2. KGS vs BLCO Comparison

KGS vs BLCO Comparison

Compare KGS & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kodiak Gas Services Inc.

KGS

Kodiak Gas Services Inc.

SELL

Current Price

$51.09

Market Cap

5.9B

Sector

N/A

ML Signal

SELL

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

SELL

Current Price

$15.80

Market Cap

6.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
KGS
BLCO
Founded
2011
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Ophthalmic Goods
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.1B
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
KGS
BLCO
Price
$51.09
$15.80
Analyst Decision
Strong Buy
Buy
Analyst Count
15
15
Target Price
★ $81.40
$19.39
AVG Volume (30 Days)
★ 1.7M
411.0K
Earning Date
11-03-2026
10-28-2026
Dividend Yield
★ 3.73%
N/A
EPS Growth
★ 58.93
N/A
EPS
★ 0.75
N/A
Revenue
N/A
★ $5,101,000,000.00
Revenue This Year
$16.21
$7.68
Revenue Next Year
$15.12
$5.95
P/E Ratio
$69.95
★ N/A
Revenue Growth
N/A
★ 6.47
52 Week Low
$32.55
$14.44
52 Week High
$77.68
$18.92

Technical Indicators

Market Signals
Indicator
KGS
BLCO
Relative Strength Index (RSI) 35.69 32.66
Support Level $51.15 $15.68
Resistance Level $52.70 $16.41
Average True Range (ATR) 2.00 0.43
MACD 0.03 -0.10
Stochastic Oscillator 25.76 20.69

Price Performance

Historical Comparison
KGS
BLCO

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. The company manages its business through two operating segments: Contract Services and Other Services. Contract Services consists of operating company-owned and customer-owned compression, gas treating, and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings. Maximum revenue for the company is generated from its Contract Services segment.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: